CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial

This publication has 30 references indexed in Scilit:

• Risk of Selecting De Novo Drug-Resistance Mutations during Structured Treatment Interruptions in Patients with Chronic HIV Infection
  Clinical Infectious Diseases, 2005
• Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting
  Journal of Clinical Microbiology, 2005
• How Soon after Infection with HIV Does the Risk of Tuberculosis Start to Increase? A Retrospective Cohort Study in South African Gold Miners
  The Journal of Infectious Diseases, 2005
• Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells
  AIDS, 2004
• Prolonged Treatment Interruption after Immunologic Response to Highly Active Antiretroviral Therapy
  Clinical Infectious Diseases, 2003
• Emergence of Minor Populations of Human Immunodeficiency Virus Type 1 Carrying the M184V and L90M Mutations in Subjects Undergoing Structured Treatment Interruptions
  The Journal of Infectious Diseases, 2003
• Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial
  AIDS, 2003
• Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Côte d'Ivoire
  AIDS, 2003
• HIV RNA in plasma rebounds within days during structured treatment interruptions
  AIDS, 2003
• Acute Human Immunodeficiency Virus Replication Causes a Rapid and Persistent Impairment of Vγ9Vδ2 T Cells in Chronically Infected Patients Undergoing Structured Treatment Interruption
  The Journal of Infectious Diseases, 2002